What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report
Home Use Lancing Devices Market Size, Share, Growth, and Industry Analysis, By Type (Adjustable Lancing Device and Non-adjustable Lancing Device) By Application (Cholesterol Tests, Glucose Tests, and Others), Regional Insights and Forecast From 2025 To 2034
Trending Insights

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
HOME USE LANCING DEVICES MARKET OVERVIEW
The global Home Use Lancing Devices Market size is projected to reach USD 0.03465 billion in 2025, growing further to USD 0.05571 billion by 2034 at an estimated CAGR of 6.12% from 2025 to 2034.
The United States Home Use Lancing Devices market size is projected at USD 0.0119 billion in 2025, the Europe Home Use Lancing Devices market size is projected at USD 0.0103 billion in 2025, and the China Home Use Lancing Devices market size is projected at USD 0.0080 billion in 2025.
Lancets, which are basically tiny needles enclosed in plastic, are used in conjunction with a lancing device to puncture tiny holes in the skin so that blood samples can be taken. Sales of lancing tools, equipment, and associated services make up the home use lancing devices market. These tools are used to prickle the skin in order to draw blood samples for the measurement of blood glucose. These home use lancing devices provide a number of benefits, including portability, accessibility, and price. As they immediately retract after pricking the skin, they are also utilized to reduce the likelihood of infections and injuries. The growing demand to do away with lancing devices and the increased usage of sterile blood lancets in blood banks will create a favorable environment for the development of the sector.
In hospitals and clinics, lancets are the preferred option for at-home diabetic monitoring. lancets also have the advantage of being portable because their needles are covered. High patient compliance, especially in the senior population, is primarily responsible for the segment's rise. The prevalence of diabetes is rising, and a variety of products are readily available, which is promoting market expansion. The market is expanding as a result of elements such as the growing choice for at-home care, the high prevalence of infectious diseases, and rising consumer knowledge of cutting-edge diabetes treatment solutions. This is primarily because of their greater utilization for diabetic home monitoring.
KEY FINDINGS
- Market Size and Growth: The global Home Use Lancing Devices Market size is projected to reach USD 0.03465 billion in 2025, growing further to USD 0.05571 billion by 2034 at an estimated CAGR of 6.12% from 2025 to 2034.
- Key Market Driver: Over 537 million adults were living with diabetes in 2023, creating high demand for home glucose testing tools like lancing devices.
- Major Market Restraint: More than 85,000 units of lancing devices were recalled in 2022 due to retraction failure and needle breakage, impacting consumer trust and usage rates.
- Emerging Trends: High-speed lancing technology adoption rose by 32% globally between 2021 and 2024 due to increased comfort, safety, and smaller puncture wounds
- Regional Leadership: North America accounted for over 43% of global diabetes-related medical spending in 2023, with the U.S. leading due to widespread self-monitoring device usage
- Competitive Landscape: Roche, Abbott, and LifeScan together cover over 55% of the global market volume, leveraging integrated lancing systems with blood glucose meters and strong retail presence.
- Market Segmentation: Adjustable lancing devices held a market share of over 68% in 2024, while glucose testing applications accounted for more than 80% of total home-use lancing device utilization.
- Recent Development: In 2023, Trividia Health launched a next-gen adjustable lancing device with 7 depth settings and ultra-thin 30G lancets, enhancing precision and reducing patient discomfort.
COVID-19 IMPACT
Halt on Manufacturing Operations to Slower Market Growth
The impact of COVID 19 on the world economy is significant. This pandemic had a significant impact on several economic sectors. The loss of enormous money will lead the world economy to weaken. The home use lancing devices market is being negatively impacted by the expanding use and application of lockdown in numerous nations. For telehealth, medical technology, home use lancing devices, and remote monitoring, COVID-19 marked the beginning of a new age. The most significant influence has been on medical and home use lancing devices, despite the fact that COVID-19's widespread effects have given rise to a situation for the world. During the pandemic, the federal government facilitated the use of and access to telehealth services, encouraging a rise in the technology's use.
LATEST TRENDS
Safer Effective Techniques to Promote Industry Progress
Diagnostic blood testing is one of the most common medical procedures, and it influences 70–80% of medical decisions. Many companies are creating safer, easier-to-use, and efficient methods for obtaining blood samples. High-speed lancing devices, which have traits like a maximum skin-piercing force and a tiny wound area, are what are causing the home use lancing devices market to rise. These devices aid patients in experiencing less pain and hastening the healing of their wounds.
- According to the World Health Organization (WHO), diagnostic blood testing supports 70–80% of medical decisions, increasing the need for accurate and safe lancing tools for self-monitoring.
- The U.S. Centers for Disease Control and Prevention (CDC) reported a 34% increase in the use of self-monitoring glucose devices between 2019 and 2023, driving innovation in lancet ergonomics and skin-friendly technology.
HOME USE LANCING DEVICES MARKET SEGMENTATION
By Type
As per the type, the market is classified as follows: Adjustable Lancing Device and Non-adjustable Lancing Device. The adjustable lancing device is the dominant segment in the home use lancing devices market share.
By Application
Based on application, the market is segmented as follows: Cholesterol Tests, Glucose Tests, and Others. The home use lancing devices market dominance is in the blood glucose testing sector. It can be attributed to the rising prevalence of diabetes and increased knowledge of blood glucose self-monitoring.
DRIVING FACTORS
Preference for Home Care to Facilitate Market Development
The market category for home care is anticipated to develop at the quickest rate during the forecast period. The market's availability of numerous home use lancing devices and growing public knowledge of blood glucose self-monitoring are two main causes of the increase. More patients prefer to monitor their blood glucose levels at home due to the low cost of doing so and the ease of doing so. Additionally, throughout the projected period, the segment growth is being driven by improvements in patient self-care using home use lancing devices globally.
Growing Demand for Home Use Lancing Devices to Boost Market Growth
The demand for home-use lancing devices is being driven by the increased prevalence of chronic diseases and the aging population. The WHO predicts that there will be 2.1 billion elderly people worldwide in 2050, up from 962 million in 2017. The market is anticipated to be driven by rising government spending and developments in diabetes control technology. During the projection period, it is anticipated that the launch of technologically sophisticated items and quicker product approvals will strengthen home use lancing devices market growth. The market is expanding as a result of technological developments and the introduction of cutting-edge lancing equipment goods.
- According to the International Diabetes Federation (IDF), 537 million adults globally were living with diabetes in 2023, with an expected rise to 643 million by 2030, pushing demand for home lancing devices.
- The United Nations Population Division projects that the global population aged 65 and older will double from 761 million in 2021 to 1.6 billion by 2050, significantly increasing self-care device adoption.
RESTRAINING FACTORS
Faults and Safety Issues to Affect Product Demand
The home use lancing devices market is being constrained by recalls of defective lancing devices. When faults or safety issues are found that jeopardize the consumer, the producer or regulatory authority will recall the product as a precaution. Devices used for lancing pierce the skin and come into direct touch with internal blood. Any flaw in the product poses a risk to the patient's life by infecting the blood. The lancet needle used for a finger stick could not fully retract into the lancet drum as it should. Such recalls deter product use and hinder home use lancing devices’ market expansion.
- The U.S. Food and Drug Administration (FDA) reported over 85,000 units of lancing devices recalled in 2022 due to faulty needle retraction, raising safety concerns among users.
- As per the European Medicines Agency (EMA), nearly 12% of users report post-lancing skin irritation or minor infection risks, limiting repeat use and impacting customer satisfaction.
-
Request a Free sample to learn more about this report
HOME USE LANCING DEVICES MARKET REGIONAL INSIGHTS
Increase in Diabetes Diagnosis to Propel Market Progress in North America
Due to its huge patient base and reimbursement regulations, North America led the market in 2019. Market expansion in the area is being aided by the rising number of new product launches and rising healthcare costs in the area. 43% of all diabetes-related medical costs are incurred in the area, according to The International Diabetes Federation. Furthermore, the development of the business will be aided by the expanding utility of lancets for diabetes diagnosis and the existence of advantageous reimbursement regulations. Increase in R&D and the introduction of technologically advanced items into the market, it is projected that the home use lancing devices market in the region would expand rapidly over the next years.
KEY INDUSTRY PLAYERS
Market Players Focus on New Product Launches to Strengthen Market Position
Leading players in the market are adopting various strategies to expand their presence in the market. These include R&D investments and the launch of new, technologically-advanced products in the market. Some companies are also adopting strategies such as partnerships, mergers, and acquisitions to strengthen their market position.
- Roche (Switzerland): According to Roche’s 2023 annual data, its Accu-Chek line reached over 26 million global users, with strong adoption in home-based diabetic management programs.
- LifeScan (U.S.): The company reported distribution of over 1.2 billion lancets worldwide in 2023, driven by OneTouch device bundling across North America and Europe
List of Top Home Use Lancing Devices Companies
- Roche (Switzerland)
- LifeScan (U.S.)
- Abbott (U.S.)
- Ascensia (U.S.)
- B. Braun (Germany)
- Terumo (Japan)
- ARKRAY (Japan)
- Trividia Health (U.S.)
- SANNUO (China)
- GMMC (Austria)
- BIONIME (Taiwan)
REPORT COVERAGE
The report covers overall market aspects, including the market segmentation based on its type and application. The report depicts a diverse group of participants that includes the market and the potential market leaders. Major factors that are expected to drive major growth in the market. The factors anticipated to expand the market share are also included in the report to offer market insights. The estimated growth of the market in the forecast period is also included in the report. The regional analysis is completed to explain the region's dominance in the global market. The factors hindering the growth of the market are discussed in detail. The SWOT analysis of the market is depicted in the report. It contains all-inclusive market details.
Attributes | Details |
---|---|
Market Size Value In |
US$ 0.034 Billion in 2025 |
Market Size Value By |
US$ 0.055 Billion by 2034 |
Growth Rate |
CAGR of 6.12% from 2025 to 2034 |
Forecast Period |
2025-2034 |
Base Year |
2024 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
|
By Type
|
|
By Application
|
FAQs
The Home Use Lancing Devices market is expected to exhibit a CAGR of 6.12% by 2034.
The Home Use Lancing Devices market is expected to reach USD 0.05571 billion by 2034.
The preference for home care and demand for home use lancing devices are the driving factors of the home use lancing devices market.
Roche, LifeScan, Abbott, Ascensia, B. Braun, Terumo, ARKRAY, Trividia Health, SANNUO, GMMC, and BIONIME are the top companies operating in the home use lancing devices market.
The UN Population Division forecasts 1.6 billion people aged 65+ by 2050, expanding the user base for home-use diabetic tools like lancing devices.
According to the CDC, 34% of diabetics in the U.S. shifted to home self-monitoring methods from 2019 to 2023, citing cost and convenience.